UB Paderborn / Katalog / Suche / in CDI

In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4276-4281

2013

Volltextzugriff (PDF)

Factors associated with mortality among hospitalized patients with COVID-19 disease treated with convalescent plasma

mBio, 2023-12, Vol.14 (6), p.e0177723

2023

Volltextzugriff (PDF)

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

Clinical infectious diseases, 2011-01, Vol.52 (1), p.31-40

2011

Volltextzugriff (PDF)

Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia

Medicina, 2022-10, Vol.82 (5), p.794

2022

Volltextzugriff (PDF)

Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3437-3441

2009

Volltextzugriff (PDF)

Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel

The Brazilian journal of infectious diseases, 2015-09, Vol.19 (5), p.543-545

2015

Volltextzugriff (PDF)

Characteristics of endemic human coronavirus infections during times of COVID-19 pandemic

Medicina, 2024, Vol.84 (1), p.102

2024

Volltextzugriff (PDF)

Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals

Journal of antimicrobial chemotherapy, 2013-12, Vol.68 (12), p.2773-2778

2013

Volltextzugriff (PDF)

RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial

EClinicalMedicine, 2021-04, Vol.34, p.100843-100843, Article 100843

2021

Volltextzugriff (PDF)

Importance of gls24 in Virulence and Stress Response of Enterococcus faecalis and Use of the gls24 Protein as a Possible Immunotherapy Target

The Journal of infectious diseases, 2005-02, Vol.191 (3), p.472-480

2005

Volltextzugriff (PDF)

Occult Staphylococcus aureus Bacteremia: Other Points to Consider

Clinical infectious diseases, 2013-06, Vol.56 (11), p.1679-1679

2013

Volltextzugriff (PDF)

Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2010-05, Vol.54 (5), p.2206-2208

2010

Volltextzugriff (PDF)

Relapse of Type A β-Lactamase-Producing Staphylococcus aureus Native Valve Endocarditis during Cefazolin Therapy: Revisiting the Issue

Clinical infectious diseases, 2003-11, Vol.37 (9), p.1194-1198

2003

Volltextzugriff (PDF)

Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections

The Brazilian journal of infectious diseases, 2016-03, Vol.20 (2), p.184-192

2016

Volltextzugriff (PDF)

Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies

Expert review of anti-infective therapy, 2012-08, Vol.10 (8), p.847-854

2012

Volltextzugriff (PDF)

A new lipoglycopeptide: telavancin

Expert opinion on pharmacotherapy, 2008-08, Vol.9 (12), p.2197-2207

2008

Volltextzugriff (PDF)

Fsr-Independent Production of Protease(s) May Explain the Lack of Attenuation of an Enterococcus faecalis fsr Mutant Versus a gelE-sprE Mutant in Induction of Endocarditis

Infection and Immunity, 2005-08, Vol.73 (8), p.4888-4894

2005

Volltextzugriff (PDF)

Decreased Virulence of a gls24 Mutant of Enterococcus faecalis OG1RF in an Experimental Endocarditis Model

Infection and Immunity, 2005-11, Vol.73 (11), p.7772-7774

2005

Volltextzugriff (PDF)

Vancomycin-Resistant Enterococcal Bloodstream Infection—Related Mortality: Focus on the Lack of Appropriate Therapy

Clinical infectious diseases, 2006-04, Vol.42 (8), p.1203-1204

Nannini, Esteban C.

2006

Volltextzugriff (PDF)

Ceftaroline for complicated skin and skin-structure infections

Expert opinion on pharmacotherapy, 2010-05, Vol.11 (7), p.1197-1206

2010

Volltextzugriff (PDF)

Activity of Tigecycline (GAR-936), a Novel Glycylcycline, against Enterococci in the Mouse Peritonitis Model

Antimicrobial Agents and Chemotherapy, 2003-02, Vol.47 (2), p.529-532

2003

Volltextzugriff (PDF)

Telavancin's interactions with the bacterial cell membrane

Future microbiology, 2010-03, Vol.5 (3), p.355-358

2010

Volltextzugriff (PDF)

Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus

Current opinion in pharmacology, 2010-10, Vol.10 (5), p.516-521

2010

Volltextzugriff (PDF)

Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature

Diagnostic microbiology and infectious disease, 2003-05, Vol.46 (1), p.49-54

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin

Factors associated with mortality among hospitalized patients with COVID-19 disease treated with convalescent plasma

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia

Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure

Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis

Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel

Characteristics of endemic human coronavirus infections during times of COVID-19 pandemic

Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals

RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial

Importance of gls24 in Virulence and Stress Response of Enterococcus faecalis and Use of the gls24 Protein as a Possible Immunotherapy Target

Occult Staphylococcus aureus Bacteremia: Other Points to Consider

Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus

Relapse of Type A β-Lactamase-Producing Staphylococcus aureus Native Valve Endocarditis during Cefazolin Therapy: Revisiting the Issue

Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections

Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies

A new lipoglycopeptide: telavancin

Fsr-Independent Production of Protease(s) May Explain the Lack of Attenuation of an Enterococcus faecalis fsr Mutant Versus a gelE-sprE Mutant in Induction of Endocarditis

Decreased Virulence of a gls24 Mutant of Enterococcus faecalis OG1RF in an Experimental Endocarditis Model

Vancomycin-Resistant Enterococcal Bloodstream Infection—Related Mortality: Focus on the Lack of Appropriate Therapy

Ceftaroline for complicated skin and skin-structure infections

Activity of Tigecycline (GAR-936), a Novel Glycylcycline, against Enterococci in the Mouse Peritonitis Model

Telavancin's interactions with the bacterial cell membrane

Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus

Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature

Suchergebnisse filtern